Patent details

EP2903591 Title: INJECTABLE STERILE AQUEOUS FORMULATION BASED ON CROSSLINKED HYALURONIC ACID AND ON HYDROXYAPATITE, FOR THERAPEUTIC USE

Basic Information

Publication number:
EP2903591
PCT Application Number:
PCT/EP/2013/069877
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137661195
PCT Publication Number:
WO/2014/056723
First applicant's nationality:
Translation Language:
EPO Publication Language:
French
English Title of Invention:
INJECTABLE STERILE AQUEOUS FORMULATION BASED ON CROSSLINKED HYALURONIC ACID AND ON HYDROXYAPATITE, FOR THERAPEUTIC USE
French Title of Invention:
FORMULATION AQUEUSE STÉRILE INJECTABLE À BASE D'ACIDE HYALURONIQUE RÉTICULÉ ET D'HYDROXYAPATITE POUR USAGE THÉRAPEUTIQUE
German Title of Invention:
INJIZIERBARE STERILE WÄSSRIGE FORMULIERUNG AUF BASIS VON VERNETZTER HYALURONSÄURE UND HYDROXYAPATIT ZUR THERAPEUTISCHEN VERWENDUNG
SPC Number:

Dates

Filing date:
24/09/2013
Grant date:
06/07/2016
EP Publication Date:
06/07/2016
PCT Publication Date:
17/04/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/08/2015
EP B1 Publication Date:
06/07/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
24/09/2016
Expiration date:
24/09/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/09/2013
 
 

Name:
Aptissen S.A.
Address:
Chemin des Aulx 18, 1228 Plan-les-Ouates, Switzerland (CH)

Inventor

Name:
GAVARD MOLLIARD Samuel
Address:
France (FR)

Priority

Priority Number:
1259582
Priority Date:
08/10/2012
Priority Country:
France (FR)

Classification

Main IPC Class:
A61K 9/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages